Inventor · disambiguated record
John W. Blankenship
Also filed as: BLANKENSHIP JOHN · BLANKENSHIP JOHN W · BLANKENSHIP JOHN WILLIAM
13 granted patents·22 pending applications·41 citations·filing 2009–2024
89Inventor score
Files withNOVARTIS AG13APTEVO RES & DEVELOPMENT LLC9BLANKENSHIP JOHN W4EMERGENT PRODUCT DEV SEATTLE4APTEVO RES AND DEV LLC3
Top patents by PatentIndex Score
35 records- 0193US12275795B2Binding molecules against BCMA and uses thereofNOVARTIS AG·Filed 2022·Granted Apr 15, 2025·2 cites·23 claims
- 0293US11492409B2Binding molecules against BCMA and uses thereofNOVARTIS AG·Filed 2019·Granted Nov 8, 2022·10 cites·26 claims
- 0390US11608382B2BCMA chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2019·Granted Mar 21, 2023·4 cites·27 claims
- 0488US11939392B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2021·Granted Mar 26, 2024·1 cites·15 claims
- 0588US10676533B2Methods of treatment of CD123 overexpressing disordersAPTEVO RES & DEVELOPMENT LLC·Filed 2018·Granted Jun 9, 2020·4 cites·9 claims
- 0687US9493564B2CD86 antagonist multi-target binding proteinsTHOMPSON PETER ARMSTRONG·Filed 2009·Granted Nov 15, 2016·12 cites·33 claims
- 0783US11242400B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Granted Feb 8, 2022·2 cites·33 claims
- 0882US12441798B2CD123 binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2024·Granted Oct 14, 2025·0 cites·15 claims
- 0981US11952428B2BCMA chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2023·Granted Apr 9, 2024·0 cites·17 claims
- 1081US11939389B2BCMA chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2023·Granted Mar 26, 2024·0 cites·90 claims
- 1180US12383601B2Chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2020·Granted Aug 12, 2025·1 cites·21 claims
- 1279US9782478B1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES AND DEV LLC·Filed 2017·Granted Oct 10, 2017·4 cites·19 claims
- 1377US2023416390A1Bcma chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1471US11352426B2CD3 binding polypeptidesAPTEVO RES & DEVELOPMENT LLC·Filed 2016·Granted Jun 7, 2022·1 cites·37 claims
- 1566US2021095046A1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2020·Application pending·0 cites
- 1659US2011217302A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2009·Application pending·0 cites
- 1757US2023081720A1Mcl-1 inhibitor antibody-drug conjugates and methods of useNOVARTIS AG·Filed 2020·Application pending·0 cites
- 1856US2018273642A1Heterodimer binding proteins and uses thereofAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 1955US2018100021A1Prostate-specific membrane antigen binding proteins and related compositions and methodsAPTEVO RES & DEVELOPMENT LLC·Filed 2017·Application pending·0 cites
- 2055US2024309084A1Degradation of extracellular targetsNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2153US2014161800A1Prostate-Specific Membrane Antigen Binding Proteins and Related Compositions and MethodsBLANKENSHIP JOHN W·Filed 2012·Application pending·0 cites
- 2252US2013095097A1Polypeptide Heterodimers and Uses ThereofBLANKENSHIP JOHN W·Filed 2010·Application pending·0 cites
- 2352US2013089554A1RON Binding Constructs and Methods of Use ThereofBLANKENSHIP JOHN W·Filed 2010·Application pending·0 cites
- 2450US2023242647A1Engineered immunoglobulinsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2550US2013189261A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2013·Application pending·0 cites
- 2650US2022332821A1Dosing regimen and combination therapies for multispecific antibodies targeting b-cell maturation antigenNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2750US2023167193A1Immunoglobulin variantsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 2848US2022396631A1Trispecific binding molecules against bcma and uses thereofHUANG LU·Filed 2020·Application pending·0 cites
- 2946US2015274844A1Heterodimer binding proteins and uses thereofEMERGENT PRODUCT DEV SEATTLE·Filed 2015·Application pending·0 cites
- 3044US2017008960A1TCR Complex ImmunotherapeuticsEMERGENT PRODUCT DEV SEATTLE·Filed 2016·Application pending·0 cites
- 3144US2022364055A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3240US2017015747A1Cd86 antagonist multi-target binding proteinsAPTEVO RES AND DEV LLC·Filed 2016·Application pending·0 cites
- 3339US2018022819A1Compositions and methods for combination therapy with prostate-specific membrane antigen binding proteinsAPTEVO RES & DEVELOPMENT LLC·Filed 2016·Application pending·0 cites
- 3437US2013129723A1Heterodimer Binding Proteins and Uses ThereofBLANKENSHIP JOHN W·Filed 2010·Application pending·0 cites
- 3530US2017089885A1Cell line-based redirected t-cell cytotoxicity assayAPTEVO RES AND DEV LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →